Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
cystetic Medicines
AddedMar 20, 2024
UpdatedJun 18, 2026
cystetic Medicines

cystetic Medicines

Series B

Innovative software & CF treatment developer in Champaign, IL.

HQ
Champaign, IL, US
Founded
2019
Overview
Compare
Fundraising
Employees

Cystetic Medicines is dedicated to developing treatments for cystic fibrosis (CF) that could benefit patients regardless of their genetic mutation. Based in Champaign, Illinois, the company focuses on innovative solutions in the healthcare sector, aiming to improve the quality of life for individuals with CF.

Cystetic Medicines has made significant strides in the biotechnology field, contributing to advancements in CF treatment. Their work has the potential to impact a broad range of patients, emphasizing inclusivity in medical care.

cystetic Medicines - Similar Companies

Celtaxsys logo

Celtaxsys

celtaxsys.com

Vertex Pharmaceuticals logo

Vertex Pharmaceuticals

vrtx.com

Synspira logo

Synspira

Citrine Medicine logo

Citrine Medicine

Sionna Therapeutics logo

Sionna Therapeutics

sionnatx.com

Cyclo Therapeutics logo

Cyclo Therapeutics

Tisento Therapeutics logo

Tisento Therapeutics

Pulmatrix logo

Pulmatrix

pulmatrix.com

Intellimedix logo

Intellimedix

Chesapeake Therapeutics logo

Chesapeake Therapeutics

Courage Therapeutics logo

Courage Therapeutics

Cantai Therapeutics logo

Cantai Therapeutics

PleoPharma logo

PleoPharma

pleopharma.com

Celnyx logo

Celnyx

RS BioTherapeutics logo

RS BioTherapeutics

cystetic Medicines - Quick Facts

Who are cystetic Medicines' competitors?

Companies similar to cystetic Medicines include Celtaxsys, Vertex Pharmaceuticals, Synspira and Citrine Medicine.

When was cystetic Medicines founded?

cystetic Medicines was founded in 2019.

Where is cystetic Medicines' headquarters located?

cystetic Medicines' headquarters is located in Champaign, IL, US.

When was cystetic Medicines' last funding round?

cystetic Medicines' most recent funding round was for $25M (USD) in December 2020.

How much has cystetic Medicines raised to-date?

As of Dec 21, 2020, cystetic Medicines has raised a total of $25M (USD).

How many employees does cystetic Medicines have?

cystetic Medicines has 7 employees as of Feb 5, 2024.

cystetic Medicines - Classification

Ownership
  • Private
Technology
  • Analytics
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Software
  • Treatment
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software